Favorable results of prophylactic donor lymphocyte transfusions following allogeneic stem cell transplantation after reduced intensity conditioning for high-risk AML and MDS

被引：0
|
作者：
Schleuning, M
Schmid, C
Ledderose, G
Tischer, J
Baurmann, H
Schwerdtfeger, R
Kolb, HJ
机构：
[1] German Diagnost Clin Fdn, Ctr hematopoiet Cell Transplantat, Wiesbaden, Germany
[2] LMU, Dept Med 3, Clin Cooperat Grp Hematopoiet Transplantat, Munich, Germany
[3] GSF, Res Ctr Environm & Hlth, Munich, Germany
来源：
EXPERIMENTAL HEMATOLOGY | 2005年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
40
引用
下载
收藏
页码：47 / 47
页数：1
相关论文
共 50 条
  • [11] Outcome of patients with high-risk AML and MDS after reduced-intensity conditioning stem cell transplantation
    Uzunov, M.
    Wittnebel, S.
    Boccaccio, C.
    Bourhis, J. H.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S209 - S209
  • [12] Allogeneic stem cell transplantation for MDS and sAML following reduced intensity conditioning and preemptive donor lymphocyte transfusion.
    Kolb, Hans-Jochem
    Schmid, Christoph
    Tischer, Johanna
    Haussmann, Andreas
    Rank, Andreas
    Schleuning, Michael
    Ledderose, Georg
    BLOOD, 2006, 108 (11) : 101A - 101A
  • [13] Favorable outcomes in elderly and high-risk patients with AML and MDS following T-cell depleted reduced intensity conditioned allogeneic stem cell transplantation
    Nicholson, E.
    Mackinnon, S.
    Thomson, K. J.
    Sudak, J.
    Fielding, A. K.
    Kottaridis, P.
    Peggs, K. S.
    Morris, E. C.
    Chakraverty, R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 : 3 - 3
  • [14] FAVORABLE OUTCOMES IN ELDERLY AND HIGH-RISK PATIENTS WITH AML AND MDS FOLLOWING T-CELL DEPLETED REDUCED INTENSITY CONDITIONED ALLOGENEIC STEM CELL TRANSPLANTATION
    Nicholson, E.
    Mackinnon, S.
    Thomson, K. J.
    Sudak, J.
    Fielding, A. K.
    Kottaridis, P.
    Peggs, K. S.
    Morris, E. C.
    Chakraverty, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S346 - S347
  • [15] Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML
    Garcia, Jacqueline S.
    Kim, Haesook T.
    Murdock, H. Moses
    Ansuinelli, Michela
    Brock, Jennifer
    Cutler, Corey S.
    Gooptu, Mahasweta
    Ho, Vincent T.
    Koreth, John
    Nikiforow, Sarah
    Romee, Rizwan
    Shapiro, Roman
    Deangelo, Daniel J.
    Stone, Richard M.
    Bat-Erdene, Denbaa
    Ryan, Jeremy
    Contreras, Manuel E.
    Fell, Geoffrey
    Letai, Anthony
    Ritz, Jerome
    Lindsley, R. Coleman
    Soiffer, Robert J.
    Antin, Joseph H.
    BLOOD ADVANCES, 2024, 8 (04) : 978 - 990
  • [16] Prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation in high-risk myeloid malignancies
    Jedlickova, Z.
    Conradi, R.
    Baurmann, H.
    Schwerdffeger, R.
    Schleuning, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S81 - S81
  • [17] Allogeneic stem cell transplantation for MDS and sAML following FLAMSA-chemotherapy, reduced intensity conditioning and preemptive donor lymphocyte transfusion
    Kolb, H. J.
    Schmid, C.
    Schleuning, M.
    Rank, A.
    Buhmann, R.
    Tischer, J.
    Valent, P.
    Ledderose, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 84 - 84
  • [18] Long-lasting remissions in high-risk AML and MDS following sequential therapy with chemotherapy, reduced-intensity conditioning for allogeneic transplantation, and prophylactic DLT
    Schmid, C
    Schleuning, M
    Hertenstein, B
    Mischak-Weissinger, E
    Bunjes, D
    Scheid, C
    Holtick, U
    Keil, F
    Sandherr, M
    Kolb, H
    BONE MARROW TRANSPLANTATION, 2005, 35 : S11 - S11
  • [19] Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation
    B Oran
    S Giralt
    D Couriel
    C Hosing
    E J Shpall
    E de Meis
    I F Khouri
    M Qazilbash
    P Anderlini
    P Kebriaei
    U Popat
    A Carrasco-Yalan
    R E Champlin
    M de Lima
    Leukemia, 2007, 21 : 2540 - 2544
  • [20] Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation
    Oran, B.
    Giralt, S.
    Couriel, D.
    Hosing, C.
    Shpall, E. J.
    de Meis, E.
    Khouri, I. F.
    Qazilbash, M.
    Anderlini, P.
    Kebriaei, P.
    Popat, U.
    Carrasco-Yalan, A.
    Champlin, R. E.
    de Lima, M.
    LEUKEMIA, 2007, 21 (12) : 2540 - 2544
12345